Aktuella utlysningar, vecka 13, 2023
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Anslag för forskning och utvecklingasarbete - Stiftelsen Sunnerdahls Handikappfond
Fonden stödjer forskning och utvecklingsarbete kring barn och ungdomar med funktionsnedsättningar. Fokus ligger på faktorer som påverkar deras hälsa, lärande
och livssituation. Anslag delas i huvudsak ut till samhällsvetenskaplig, pedagogisk och medicinsk forskning. Forskning på hög vetenskaplig nivå som är nyskapande och gäller för hela
målgrupper prioriteras. Bidrag ges i regel till tio till femton projekt med maximalt drygt 350 000 kronor. Bidrag ges för ett år i taget, bidrag kan ges under maximalt tre år till samma projekt.
Closing date: April 30, 2023
Urgent call ensuring the future availability of data or research materials - Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
Formas welcomes applications within any of its areas of responsibility that show an urgent need to ensure future availability of primary research data, such as measurement data and collected samples, interviews and participating observations. The urgent need to ensure access to research data must be based on a phenomenon or sudden situation that could not be predicted. The data should show great promise to lead to significant scientific results and real-world impact. The grant amount must correspond only to the costs that will be incurred for urgently securing research materials and primary data for future research. Maximum grant duration is one year. The size of the grant is a maximum of SEK 1 million.
Closing date: May 24, 2023 at 14:00
Forskningsanslag inom strålningsbiologi och strålningsdosimetri - Strålsäkerhetsmyndigheten
Strålsäkerhetsmyndigheten (SSM) utlyser härmed medel för forskning inom skydd mot skadliga effekter av joniserande strålning. Forskningsområden som omfattas av denna utlysning är främst strålningsbiologi och strålningsdosimetri men även strålskydd inom beredskap och sjukvård. Utlysningen avser medel för doktorandtjänster, post-doktorandtjänster eller forskningsprojekt. En ansökan om medel kan även utgöras av eller till viss del omfatta inköp av utrustning som är nödvändig för forskningen.
Closing date: April 24, 2023
Preparatory projects for international proposal in health and food – VINNOVA
Swedish Governmental Agency for Innovation Systems (VINNOVA) invites applications for its preparatory projects for international proposal in health and food call. This enables the preparation of proposals for future applications in an international call in the area of health or in food systems. The aim is to strengthen the project proposals to increase the chance of funding. Project activities may include increasing the scientific base for the project, strengthen the business acumen by conducting intellectual property rights analyses, user interviews or develop a first business plan. Consortium strengthen activities such as meetings and discussions with potential international parties as well as internal resources for designing a competitive application may also be included.
This enables the preparation of proposals for future applications in an international call in the area of health or in food systems. Grants are worth between SEK 200,000 and SEK 300,000 and may last between two to 12 months.
Closing date: June 2, 2023
Stipendium för reumatologiska forskningen till minne av Nanna Svartz – Reumatikerförbundet och Pfizer
Syftet med stipendiet är att uppmuntra patientnära forskning i Sverige, samt att bidra till ökat intresse och kännedom om den reumatologiska forskningen bland sjukvårdspersonal, beslutsfattare och allmänhet. Stipendiet är på 150 000 kr.
Closing date: May 1, 2023
Stipendium för teamsamarbete inom reumavården – Reumatikerförbundet och Pfizer
Anslaget syftar till att uppmuntra utveckling av och forskning om teamsamarbete inom reumavården för att skapa mervärde och förbättrad livskvalitet hos personer med reumatisk sjukdom.
Anslaget omfattar 50 000 kr och ska användas för utvecklings- eller forskningsprojekt kopplat till reumatologiområdet.
Closing date: May 1, 2023
Stipendium för utveckling av reumatisk omvårdnad - Föreningen Reumasjuksköterskor i Sverige (FRS) och Novartis
Stipendier om 50 000 kr delas för utvecklande av vården av reumatiskt sjuka patienter. Stipendier är av yrkesförkovrande natur och kan sökas av medlemmar i FRS som behöver ekonomiskt stöd för att genomföra projekt eller forskning som syftar till att förbättra och/eller utvärdera omvården för patienter med reumatiska sjukdomar. Syftet med stipendiet är att stödja och uppmärksamma sjuksköterskor som på ett strukturerat och vetenskapligt sätt arbetar för utvecklandet av reumatologisk omvårdnad
Closing date: May 1, 2023
Other grants - Swedish Childhood Cancer Foundation (Barncancerfonden)
- Travel grants to the researchers within the area of children oncology;
- Grants for methodological studies abroad (up to three months) to researchers within the area of children oncology;
- Grants for organization of research symposia;
- Guest lecturer - funds visits by prominent international guest lecturers in the field of paediatric oncology;
- Start-up grants for international, phase III/IV multi center studies on treatments against childhood cancer;
- Educational courses - enables researchers within the area of paediatric oncology to attend educational courses abroad for up to three months.
Closing date: May 15, 2023
Apply for seed grants for collaborative research with partners in South Africa
SASUF 2030 is a strategic internationalisation project uniting 40 universities from Sweden and South Africa. In collaboration with the National Research Foundation (NRF) of South Africa they now open a call.
The call for South Africa Sweden University Forum (SASUF)-NRF seed grants for collaborative research is now open. Deadline is 28 April 2023. More information and guidelines are found at SASUF's page.
Closing date: April 28, 2023
Contact: Johanna Ackemar
Rolf Luft fellowship/stipend 2023 - for junior researchers in diabetes and metabolism
The Board of Rolf Luft Foundation for Diabetes Research has decided to announce fellowship/stipend 2023 to young researchers (post doc, 0-3 years after dissertation) at Universities in Sweden. 40 000 SEK is available for travel grants and/or fellowships to study at another University.
The application in English should include the following:
− Research plan (max 2 pages), CV including a list of publications.
− A short letter of recommendation from research group leader.
− Letter of invitation from the University to visit (from the supervisor to be).
− A budget. The application must state if the fellowship will be used for travel costs and/or for personal living costs during the post doc period.
To apply, please use the enclosed form with the applicant´s name, postal address (university, home) and e-mail address.
The application shall be sent by e-mail to email@example.com, or in three copies to the Rolf Luft Foundation for Diabetes Research, c/o Kerstin Brismar, Sonja Kovalevskys gata 2, lgh 1803, 113 66 Stockholm by May 31, 2023
CBCS Large Projects Call Spring 2023 - SciLifeLab Anubis
The Chemical Biology Consortium Sweden (CBCS) is a national research infrastructure in Sweden funded by the Swedish Research Council, Science for Life Laboratory, and the host universities. We provide world-leading expertise in the field of chemical biology to academic groups across Sweden in a collaborative project model. Our mission is to explore complex biology through the development and application of small molecule tools. To do this we provide support in assay development, small molecule screening, enabling chemistry, as well as access to small-molecule libraries. Additionally, we have recently expanded our services to include disease and compound profiling using Cell Painting, support for functional precision medicine projects, screening of infectious pathogens in biosafety level 2 and 3 laboratories, and automated patch clamp profiling/screening.
We are looking for projects in these areas to support starting August 2023. All applications are ranked by our external project review committee based on scientific potential and feasibility. Prioritized projects receive subsidized support. We require a demonstration of technical feasibility thus we require that you contact CBCS well in advance of the final deadline. See www.cbcs.se for your nearest point of contact.
Deadline: 2023-04-14 12:00 CEST
STINT - En ny programportfölj för 2023
STINTs styrelse har vid styrelsemötet den 16 december 2022 beslutat att fokusera STINTs programportfölj på tre flaggskeppsprogram:
• Strategic Grants for Internationalisation för strategisk internationalisering på lärosätesnivå, med medel för yngre forskares internationella mobilitet
• STINT International Postdoc för internationalisering av yngre forskare
•Teaching Sabbatical för internationalisering av högre utbildning, speciellt undervisning
Utöver dessa program utlyses även Initiation Grants två gånger under 2023. Programmet Mobility Grants pausas och utlyses framöver för speciella riktade insatser efter behov. Med dessa förändringar renodlas programportföljen och STINTs projektinvesteringar koncentreras till tre flaggskeppsprogram.
Initiation Grants ges för genomförandet av kortvariga projekt som syftar till uppbyggnaden av nya och strategiskt intressanta internationella relationer.
Ansökan kan skickas in fortlöpande under året fram till 12 juni 2023. Vid följande datum under 2023 inleds bedömning av inkomna ansökningar: 3 april och 12 juni 2023 kl 15:00.
Meeting organiser grants - Federation of European Microbiological Societies (FEMS)
The Federation of European Microbiological Societies invites applications for its meeting organiser grants. These support scientific conferences, laboratory workshops and training courses held in Europe.
A minimum of 60 per cent of the total grant value must be used to support the attendance of early-career scientists. Grants are worth up to €15,000 each.
Closing date: 1 June 2023
Heinrich Wieland prize - Boehringer Ingelheim Foundation
The Boehringer Ingelheim Foundation invites nominations for the Heinrich Wieland prize. This recognises research on biologically active molecules and systems in the fields of chemistry, biochemistry and physiology, and their clinical importance.
Self-nominations are not permitted. The prize is worth €100,000.
Closing date: 1 June 2023
Osteology researcher grants - Osteology Foundation
The Osteology Foundation invites applications for its osteology research grants. These support research on oral tissue regeneration. Topics may include:
•hard and soft tissue biology;
•novel bone and soft tissue substitute materials;
•local factors affecting oral tissue regeneration;
•systemic diseases with an impact on oral tissue regeneration;
•pharmacological aspects of oral tissue regeneration;
•inflammatory conditions, such as periodontitis and peri-implantitis.
Applications are open to advanced researchers in the field of oral tissue regeneration and young researchers currently undergoing postgraduate education or within three years thereafter. Grants for advanced researchers are worth up to CHF 100,000 each for projects lasting up to two years. Grants for young researchers are worth up to CHF 30,000 each for projects lasting up to one year.
Closing date: 15 June 2023
Advanced research grants in amyotrophic lateral sclerosis - Radala Foundation for ALS Research
The Radala Foundation invites applications for its advanced research grants in amyotrophic lateral sclerosis (ALS). These support potentially ground-breaking, high-risk projects in basic research in ALS.
Established, leading PIs may apply. They are expected to be active researchers and have a track-record of significant research achievements in the last 10 years. Research must be conducted in a public or private research organisation. There are no geographical limitations.
Up to two grants are available, each worth CHF 200,000 over two years.
Closing date: 30 June 2023
Research grants - European Society for Surgery of the Shoulder and the Elbow
These support basic and clinical research related to shoulder and elbow pathologies. The aim is to foster projects that provide useful information and develop and provide methodological tools for the benefit of our society. Ordinary, associate- or corresponding members are eligible for application. The application can be authored or co-authored by non-members provided that there is at least one SECEC/ESSSE member in the author's list. Methodological and epidemiological projects will be favoured. Funding for a maximum of 20,000 Euro will be provided.
Closing date: 30 June 2023
CDMRP - Epilepsy Research Program (ERP)
Funded programs: Idea Development Award, Leveraging Research Award, Research Partnership Award, Virtual Post-Traumatic Epilepsy Research Center - Faculty Award
Upcoming deadlines: LOI -May 19th , 2023; Full application – June 23rd , 2023.
Abstract: To be considered for funding, applications for the FY23 ERP Research Award must address a critical component of at least one of the Areas of Emphasis listed below, unless adequate justification for exception is provided.
• Markers and Mechanisms: Identifying biomarkers or mechanisms of post-traumatic epilepsy (PTE), which may include the following:
- Predictive biomarkers of epileptogenesis (acute and chronic);
- Research into the prevention of epilepsy and/or seizures.
• Epidemiology: Epidemiological characterization of PTE following TBI, which may include the following:
- Understanding and improving the quality of life of individuals with PTE, their families, and/or their care partners;
- Predictors of the development of epilepsy ○ Outcomes, including latency to and prevention of epilepsy, comorbidities, and mortality.
• Longitudinal Studies: Studies of the evolution of PTE, which may include the following:
- Understanding and improving the quality of life of individuals with PTE, their families, and/or their care partners;
- Treatment and healthcare outcomes research, including quality of care ○ Natural history of PTE and prognosis;
- Comorbidities (e.g., depression, functional deficits, sleep disorders, major illness).
• Innovative Research: Tools intended to better inform or improve upon PTE research and care, which may include the following:
- Strategies that will improve seizure detection, characterization, visualization, or diagnosis;
- Development of new models or better characterization of existing etiologically relevant models for PTE.
CDMRP - Peer Reviewed Alzheimer's Research Program (PRARP)
Funded programs: Transforming Care Award (TCA); Transforming Diagnosis Award (TDA); Transforming Research Award (TRA)
Upcoming deadlines: LOI -May 31st , 2023; Full application – July 10th , 2023.
Abstract: The FY23 PRARP TCA is responsive to the Individual, Family, and Care-Partner Support Focus Area, which prioritizes the lived experiences of persons living with AD/ADRD. This Focus Area targets research that includes, but is not limited to, improvements in long-term care, quality of life, psychosocial wellness and support, and community and home resources supporting aging in-place and community living for individuals living with dementia, their families, and care partners.
To address the intent of the award mechanism, applications submitted to this program announcement must address the FY23 PRARP TDA Diagnostic, Environmental, and Prognostic Factors Focus Area.
To meet the intent of the award mechanism, applications submitted to this program announcement must address the FY23 PRARP TRA Prevention and Risk Reduction Focus Area.
CDMRP - Tuberous Sclerosis Complex Research Program (TSCRP)
Funded programs: Clinical Translational Research Award (CTRA); Exploration - Hypothesis Development Award (EHDA); Idea Development Award (IDA).
Upcoming deadlines: LOI -June 8th, 2023; Full application – July 7th, 2023.
Abstract: The FY23 TSCRP Research Award encourages applications that address one or more of the following Focus Areas:
- Understanding, preventing, and treating the features of TSC-Associated Neuropsychiatric Disorders (TAND) and reducing their impact, including pharmacological, behavioral, and surgical interventions
- Strategies for eradicating tumors associated with TSC and TSC-associated lymphangioleiomyomatosis (LAM), including gaining a deeper mechanistic understanding of tumor microenvironment, TSC signaling, and mTOR independent pathways
- Preventing epilepsy, improving treatment, and mitigating neurodevelopmental and adverse outcomes associated with TSC-related seizures
- Developing, assessing, and testing emerging technologies including imaging and molecular therapeutic strategies, such as gene therapy, to improve outcomes in TSC
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional), NIH
Funder's opportunity ID: PAR-23-269
Upcoming deadlines: August 15, 2023; August 14, 2024; August 14, 2025
The NIDA Avant-Garde Award Program for HIV Research supports exceptionally creative scientists, who propose high-impact studies that open new areas of HIV research in the context of substance use and Substance Use Disorders (SUD) and/or lead to new avenues for prevention and treatment of HIV in people with SUD. The term “avant-garde” refers to highly innovative ideas and/or approaches that have the potential to be transformative. Accordingly, applications responding to this FOA must propose pioneering research that aligns with the NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-018.html and is substantially different from what is currently being pursued by the principal investigator or others in the field. In essence, this funding opportunity supports innovative basic, clinical and translational research that may lead to improved therapies or preventive interventions for HIV in people with SUD. Some examples of research studies include developing creative strategies to prevent HIV transmission in high-risk substance using populations, to improve outcomes of HIV and HIV-related comorbidities, and to achieve functional or sterilizing cure of HIV.
Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed), NIH
Funder's opportunity ID: RFA-AI-23-018
Upcoming deadlines: August 02, 2023
This Notice of Funding Opportunity (NOFO) encourages research focused on defining the molecular mechanisms by which HIV proteins and/or nucleic acids induce inflammation, immune activation and HIV persistence during viral suppression as well as on developing novel therapeutic strategies to mitigate or eliminate the effects of continued HIV expression.
Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional), NIH
Funder's opportunity ID: RFA-MH-23-140
Upcoming deadlines: June 21, 2023
This Notice of Funding Opportunity (NOFO) seeks research applications for effectiveness and implementation science on the post-acute (long-term or chronic) management of mental health conditions. This NOFO aims to advance the development of novel and innovative implementation research to improve the availability and accessibility of post-acute services in low- and middle-income countries (LMICs). All research applications must propose a cost analysis of the intervention that is studied.
RFA-MH-23-140: Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional) (nih.gov)
Transformative Research Award, Hereditary Disease Foundation (HDF), US
Upcoming deadlines: April 15, 2023 (LOI); May 15, 2023 (Invitation to the full proposal); July 15, 2023 (Full proposal); September 15, 2023 (Award Announcement).
Amount: $300,000-500,000 per award per year with appropriate justification for up to a two-year period.
Eligibility: Investigators from academic institutions, companies, national laboratories, nonprofit institutes, and multi-institutional teams are welcome to apply. Partnerships between academia and industry and those bringing scientific expertise from outside the HD field are strongly encouraged.
Abstract: This program is intended to stimulate revolutionary advances in discovering fundamental new disease mechanisms or conceptually novel therapeutic approaches. Exceptional novelty with a credible research path toward the envisioned outcome that will impact HD research or HD therapies will be the most important factor in funding decisions. Incremental advances on research already described in the literature are excluded. This funding opportunity is exclusively to develop and test new ideas.
Proposers are expected to establish their own metrics and milestones to measure success and to provide justification for their choice of metrics. Progress metrics must be delineated.
Single-Cell Biology Data Insights, Chan Zuckerberg Initiative (CZI), US
Upcoming deadlines: LATE-JUNE 2023 (Cycle 3)
Amount: up to $400,000 total costs for Expanded Projects and $200,000 total costs for Focused Projects. All projects’ awards will be for an 18-month duration.
Eligibility: Applications may be submitted by domestic and foreign nonprofit organizations including public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government, and eligible agencies of the federal government.
Abstract: The Chan Zuckerberg Initiative (CZI) seeks applications for projects that aim to use and gain insights into health and disease from existing single-cell datasets to help accelerate progress toward challenges associated with the compilation and exploration of large atlas-scale data. Given the growth of single-cell biology and the rapid increase in available data, CZI is looking to support projects that will advance the fields of single-cell biology and data science. Grantees will be expected to interact with a network among participating groups that builds community and accelerates progress.
The goal of this opportunity is to create a network of projects that address broad computational challenges and needs within single-cell biology at a variety of scales. If applicants wish to highlight existing or prospective collaboration among projects, that is encouraged and allowable, but all applications will be reviewed for their individual merit and impact.